Blaxter, K.L. : The fat-soluble vitamins. Ann. Rev. Biochem., 26: 275, 1957.
3.
Fieser, L.F. , Tishler, M., AND Sampson, W.L.: Vitamin K activity and structure. J. Biol. Chem., 141: 659, 1941.
4.
Campbell, H.A. , Smith, W.K., Roberts, W.L., AND Link, K.P.: Studies on the hemorrhagic sweet clover disease. J. Biol. Chem., 138: 1, 1941.
5.
Owen, C.A., AND Bollman, J.L.: Prothrombin conversion factor of Dicumarol plasma. Proc. Soc. Exper. Biol. &Med., 67: 231, 1948.
6.
Koller, F., Loeliger, A., AND Duckert, F.: Le facteur VII. Sa fonction dans la coagulation. Son importance clinique. Rev. hémat.,7: 156, 1952.
7.
Biggs, R., Douglas, A.S., Macfarlane, R.G., Dacie, J.V., Pitney, W.R., Mer-Skey, C., AND O'Brien, J.R.: Christmas disease; a condition previously mistaken for hemophilia. Brit. M. J.,2: 1378, 1952.
8.
Aggler, P.M. , White, S.G., Glendening, M.B., Page, E.W., Leak, T.B., AND Bates, G.: Plasma thromboplastin component (PTC) deficiency: a new disease, resembling hemophilia. Proc. Soc. Exper. Biol. &Med., 79: 692, 1952.
9.
Sise, H.S., Adamis, D., AND Kimball, D.M.: Plasma thromboplastin component (PTC) deficiency produced by prolonged administration of prothrombopenic anticoagulants. Proc. Soc. Exper. Biol. &Med., 89: 81, 1955.
10.
Johnson, S.A. , AND Seegers, W.H.: Reduction of autoprothrombin II activity with Dicumarol. Circulation Res., 4: 182, 1956.
11.
Naeye, R.L. : Plasma thromboplastin component: Influence of coumarin compounds and vitamin K on its activity in serum. Proc. Soc. Exper. Biol. &Med., 91: 101, 1956.
12.
Lewis, J.H., Ferguson, J.H., Spaugh, E., Fresh, J.W., AND Zucker, M.B.: Acquired hypoprothrombinemia. Blood, 12: 84, 1957.
13.
Spaet, T.H., AND Kropatkin, M.: Studies on prothrombin derivatives in vitamin K deficiency. A. M. A. Arch. Int. Med., 102: 558, 1958.
14.
Douglas, A.S. : Some observations on the coagulation defect in vitamin K deficiency. J. Clin. Path.,11: 261, 1958.
15.
Hoffman, G.C. , AND Hewlett, J.S.: Deficiencies in Stuart (Prower) factor, plasma thromboplastin component, prothrombin, and factor VII, due to malabsorption of vitamin K. Cleveland Clin. Quarterly, 26: 15, 1959.
16.
Spaet, T.H. , AND Kropatkin, M.L.: Warfarin-induced deficiency of PTC in rats and its correction with vitamin K. Fed. Proc., 16: 121, 1957.
17.
Bachmann, F. , Duckert, F., Flückiger, P., Hitzig, W., AND Koller, F.: Über einen neuartigen kongenitalen Gerinnungsdefek (Mangel and Stuart-Faktor). Thrombosis et Diathesis Haemorrhagica , 1: 87, 1957.
18.
Seegers, W.H. , Alkjaersig, N., AND Johnson, S.A.: Formation of autoprothrombin in solutions containing purified prothrombin and purified platelet factor 3. Am. J. Physiol., 181: 589, 1955.
19.
Lasch, H.G. , AND Roka, L.: Zur Prothrombinbildung in der Leber. Hoppe- Seyler's Ztschr. physiol. Chem.,294: 30, 1953.
20.
Alkjaersig, N., AND Seegers, W.H.: Formation of prothrombin from autoprothrombin by means of liver mitochondria. Am. J. Physiol., 183: 111, 1955.
21.
Seegers, W.H. , AND Johnson, S.A.: Conversion of prothrombin to autoprothrombin II and its relation to the blood clotting mechanisms. Am. J. Physiol., 184: 259, 1956.
22.
Johnson, S.A. , Caldwell, M.J., AND Priest, E.M.: The effect of the oral anticoagulant "Marcumar" on prothrombin and related components of the blood coagulation mechanisms . Circulation Res., 5: 252, 1957.
23.
Johnson, S.A. , Caldwell, M.J., AND Priest, E.M.: Effect of administration of phenindione on blood levels of prothrombin, autoprothrombin I and autoprothrombin II. J. Appl. Physiol., 13: 411, 1958.
24.
Ware, A.G., AND Seegers, W.H.: Two-stage procedure for the quantitative determination of prothrombin concentration . Am. J. Clin. Path.19: 471, 1949.
25.
Seegers, W.H. , Casillas, G., Shepard, R.S., Thomas, W.R., AND Halick, P.: Some properties of thrombin preparations . Canad. J. Biochem. & Physiol., accepted for publication.
26.
Carter, J.R. , AND Warner, E.D.: Concept of a common protein moiety, containing disulfide bonds, in prothrombin, prothrombin derivative (autoprothrombin) and thrombin. Am. J. Physiol.,184: 195, 1956 .
27.
Johnson, S.A. AND Seegers, W.H.: Use of purified prothrombin in the study of hemophilia and plasma thromboplastin component (PTC) deficiency. J. Appl. Physiol., 6: 429, 1954.
28.
Mushett, C.W. , Kelley, K.L., AND Hirsch-Mann , R.: Efficacy of water-soluble derivatives of vitamin K1 in counteracting drug-induced hypoprothrombinemia . Blood,14: 37, 1959.
29.
Seegers, W.H. , Loomis, E.C., AND Vanden-Belt , J.M.: Preparation of prothrombin and its properties. Arch. Biochem., 6: 85, 1945.
30.
Schneider, C.L., Claxton, E.B., Hughes, C.H., AND Johnson, S.A.: Bovine platelets in large quantities, properties and activities concerned with hemostasis. Am. J. Physiol. , 179: 236, 1954.
31.
Brecher, G. , Schneiderman, M., AND Cron-Kite, E.P.: The reproducibility and constancy of the platelet count. Am. J. Clin. Path., 23: 15, 1953.
32.
Mertz, E.T. , AND Owen, C.A.: Imidazole buffer: Its use in blood clotting studies Proc. Soc. Exper. Biol. &Med., 43: 204, 1940.
33.
Owen, JR., C.A., Hurn, M.M., AND Mann, F.D.: Dextran as a substitute for acacia in the assay of plasma prothrombin. Am. J. Clin. Path.,25: 1279, 1955.
34.
Quick, A.J. : Nature of bleeding in jaundice. J. A. M. A., 110: 1658, 1938.
35.
Seegers, W.H. , AND Smith, H.P.: Factors which influence the activity of purified thrombin. Am. J. Physiol., 137: 348, 1942 .
36.
Lasch, H.G. , Pfisterer, I., AND Schimpf, K.: Üeber das Verhalten des Gerinnungsfaktors VII im Kreislauf der Katze. Acta haemat.,17: 280, 1957.